Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada. more
Time Frame | QNTM | Sector | S&P500 |
---|---|---|---|
1-Week Return | -15.68% | 0.31% | -1.26% |
1-Month Return | -20.96% | 0.6% | -4.16% |
3-Month Return | -31.95% | -9.44% | -0.46% |
6-Month Return | -64.96% | -5.15% | 3.58% |
1-Year Return | -94.46% | 0.33% | 22.47% |
3-Year Return | -95.1% | 4.53% | 25.13% |
5-Year Return | -99.13% | 35.98% | 77.7% |
10-Year Return | -99.71% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 2.04M | - | - | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Profit | (1.84M) | - | - | - | - | [{"date":"2019-12-31","value":-184265121,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | - | 30.60M | 33.74M | 27.43M | 19.57M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":90.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.29,"profit":true},{"date":"2023-12-31","value":58,"profit":true}] |
Operating Income | - | (30.60M) | (33.74M) | (27.43M) | (19.57M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3060122800,"profit":false},{"date":"2021-12-31","value":-3374366000,"profit":false},{"date":"2022-12-31","value":-2742961100,"profit":false},{"date":"2023-12-31","value":-1957011400,"profit":false}] |
Total Non-Operating Income/Expense | - | 2.15M | (194.30K) | 725.95K | 1.34M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-9.04,"profit":false},{"date":"2022-12-31","value":33.78,"profit":true},{"date":"2023-12-31","value":62.33,"profit":true}] |
Pre-Tax Income | - | (28.45M) | (33.94M) | (26.70M) | (18.23M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2845223200,"profit":false},{"date":"2021-12-31","value":-3393795600,"profit":false},{"date":"2022-12-31","value":-2670366200,"profit":false},{"date":"2023-12-31","value":-1823058800,"profit":false}] |
Income Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | - | (28.45M) | (33.94M) | (26.70M) | (18.23M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2845223200,"profit":false},{"date":"2021-12-31","value":-3393795600,"profit":false},{"date":"2022-12-31","value":-2670366200,"profit":false},{"date":"2023-12-31","value":-1823058800,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | - | (31.80M) | (35.29M) | (23.61M) | (17.90M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3179979300,"profit":false},{"date":"2021-12-31","value":-3528542900,"profit":false},{"date":"2022-12-31","value":-2360682800,"profit":false},{"date":"2023-12-31","value":-1790217900,"profit":false}] |
EPS (Diluted) | (340.58) | (189.74) | - | - | (124.85) | [{"date":"2019-12-31","value":-34057.81,"profit":false},{"date":"2020-12-31","value":-18973.83,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-12484.69,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
QNTM | |
---|---|
Current Ratio | 3.76 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
QNTM | |
---|---|
ROA (LTM) | -36.12% |
ROE (LTM) | -63.89% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
QNTM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.19 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.86 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
QNTM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 91.86 |
P/B | 0.55 |
Price/FCF | NM |
EV/R | 98.56 |
EV/Ebitda | NM |
Quantum BioPharma Ltd. (QNTM) share price today is $3.28
Yes, Indians can buy shares of Quantum BioPharma Ltd. (QNTM) on Vested. To buy Quantum BioPharma Ltd. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNTM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Quantum BioPharma Ltd. (QNTM) via the Vested app. You can start investing in Quantum BioPharma Ltd. (QNTM) with a minimum investment of $1.
You can invest in shares of Quantum BioPharma Ltd. (QNTM) via Vested in three simple steps:
The 52-week high price of Quantum BioPharma Ltd. (QNTM) is $70.85. The 52-week low price of Quantum BioPharma Ltd. (QNTM) is $2.7.
The price-to-earnings (P/E) ratio of Quantum BioPharma Ltd. (QNTM) is
The price-to-book (P/B) ratio of Quantum BioPharma Ltd. (QNTM) is 0.55
The dividend yield of Quantum BioPharma Ltd. (QNTM) is 0.00%
The market capitalization of Quantum BioPharma Ltd. (QNTM) is $6.30M
The stock symbol (or ticker) of Quantum BioPharma Ltd. is QNTM